CRY1 and cancer: The observation that CRY1 is associated with poor outcome in metastatic PCa, coupled with linkage of the newly identified CRY1 cistrome to cancer-promoting pathways, suggests that CRY1 plays roles distinct from circadian regulation in PCa.